Tech Company Financing Transactions
Ambrx Funding Round
5AM Ventures and Tavistock Life Sciences participated in a $12.5 million Series A venture round for Ambrx. The funding round was announced on 9/22/2003.
Transaction Overview
5AM Ventures (Lead Investor) (John Diekman)
Company Information
La Jolla, CA 92037
USA
Management Team
Browse more venture capital transactions:
Prev: 9/22/2003: RadioFrame Networks venture capital transaction
Next: 9/22/2003: Nuasis venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs